User:Grant Drewyor/sandbox

= RightBio Metrics = RightBio Metrics is a medical technology company primarily known for the RightSpotpH® Indicator product line. This technology is used in medical practices for the accurate placement of nasogastric and orogastric tubes. The RightSpotpH® Indicator is noted for its role in patient safety and clinical efficiency.

History and Development
RightBio Metrics was founded in 2005 by Paul Gilbert, MD and Robert Gilbert, MD. The company has stated its primary goal as “...eradicating harm caused by misplaced NG/OG tubes through innovative and accurate biofluid measurement solutions, ensuring the highest standards of patient safety and care in healthcare settings.” The development of the RightSpotpH® Indicator, which was launched in 2011, was a significant milestone for the company, introducing a new method for verifying nasogastric and orogastric tube placement via pH.

RightSpotpH® Indicator
The RightSpotpH® Indicator is a medical device designed for verifying the correct placement of nasogastric and orogastric tubes. It functions based on pH measurement, providing an enclosed system for healthcare professionals to determine that a tube has been placed into the patient’s stomach successfully. Traditional tube placement confirmation methods, such as auscultation, have been noted for the danger they pose to patients due to their unreliable nature. In contrast, the RightSpotpH® Indicator has been recognized for its simplicity and effectiveness in preventing procedural risks resulting from incorrect tube placement, such as aspiration pneumonia.

Applications in Medical Practice
Indicated for neonates, pediatrics, and adults, the RightSpotpH® Indicator is used to ensure the safety and accuracy of nasogastric and orogastric tube placement, a common procedure in hospital settings and an important aspect of intensive care situations. Beyond hospitals, the RightSpotpH® Indicator also provides the ability to easily and safely test and confirm the placement of NG/OG tubes in homecare settings.

Research and Clinical Studies
Research published in the National Library of Medicine highlights the effectiveness of the RightSpotpH® Indicator in neonatal settings, emphasizing its role in clinical outcomes. A clinical study published in The Journal of Perinatal & Neonatal Nursing on enteral tube placement discusses the significance of accurate tube placement and the role of pH measurement. An NCBI study on feeding tube placement supports the importance of precise placement techniques, underscoring the relevance of pH-based verification methods.

Guidelines and Safety Standards
The National Patient Safety Agency (NPSA) in the UK has set guidelines on tube placement that have informed the development and application of the RightSpotpH® Indicator. The NHS has issued guidelines and safety alerts on nasogastric tube placement, stressing the need for verification technologies. Perspectives from the AACN on critical care nursing address the challenges in feeding tube placement, an area where RightBio Metrics' technology is applied.

Patient Safety and Clinical Impact
Assessments of patient safety risks in tube placement from the Children's Hospital Association highlight the necessity of reliable verification methods. The article presents pH testing as a reliable method for testing the accuracy of NG tube placement.

Regulatory Approvals and Compliance
RightBio Metrics' RightSpotpH® Indicator has received FDA approval and is CLIA-waived. The company adheres to international standards and maintains a commitment to quality and regulatory compliance.

Industry Recognition and Outreach
RightBio Metrics has received industry recognition for its technology. One such award presented to the company was the Patient Safety Innovation Award given by the Patient Safety Movement Foundation to RightBio Metrics during the 6th Annual World Patient Safety, Science & Technology Summit held in London, England in 2015. Other recognition has been given to RightBio Metrics by healthcare industry professionals such as the Florida Hospital Tampa Pepin Heart Institute and University of Florida College of Medicine.

Future Directions and Ongoing Research
RightBio Metrics continues to invest in research and development, with the goal of enhancing the RightSpotpH® Indicator and exploring new areas in medical technology. The company has an apparent focus on advancing patient safety and medical procedures through its technological innovations.